Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance Today
Country
Cannabis and hemp laws
Cannabis illegal with zero-tolerance; only Sativex routine; hemp flower treated as narcotic
Sweden
Sweden
FAQ
No, cannabis is illegal in Sweden for every purpose, and Sweden criminalizes something most countries do not: being high. Under the Narcotic Drugs Criminal Act (Narkotikastrafflag 1968:64), use itself has been a crime since 1988, and since 1993 police who reasonably suspect drug use can compel a urine or blood test on the spot.
CBD is legal in Sweden with some of the EU's strictest requirements, zero detectable THC and novel food compliance. Sweden requires CBD products to contain zero detectable THC (not simply 0.2% or 0.3%), and ingestible CBD products require a valid EU Novel Food authorization.
Industrial hemp cultivation is legal in Sweden but tightly restricted. Farmers may grow only EU-certified Cannabis sativa L. varieties listed in the EU Common Catalogue with a THC content not exceeding 0.3%, and must register their fields with Jordbruksverket (the Swedish Board of Agriculture) to claim CAP support payments.
Cannabis import and export are prohibited; bringing any THC product into Sweden, including CBD oils with trace THC that are legal elsewhere in the EU, is a smuggling offence prosecuted alongside the Narkotikastrafflag. CBD products may be imported into Sweden only with zero detectable THC and EU Novel Food compliance for ingestibles, or EU Cosmetics Regulation compliance for topicals.
This is general information, not legal advice.
Swedish case law treats cannabis seeds as outside the Narcotic Drugs Penal Act (1968:64) because seeds contain no THC, so possessing or receiving them is not a narcotics offence, but germinating a seed is cultivation and selling seeds to facilitate growing risks complicity liability. Industrial hemp escapes the narcotics definition only when EU-catalogue varieties are grown on registered agricultural land under CAP rules, and the Medical Products Agency proposed tightening this exemption in a 2024 report.